The refractory gout market is growing because of the rising prevalence of gout brought on by aging populations and changes in ...

In a significant milestone for Ayurvedic medicine, Amrith Noni has successfully completed human clinical trials for its ...

XORTX to focus on late stage allopurinol intolerant gout program; discussion with FDA planned for first half 2025 regarding ...

The NHS has listed what it believes to be the 20 top most painful conditions a person can suffer from. While there are ...

In addition to adherence challenges, discontinuation of prescription treatment due to adverse effects is also a challenge in the medical management of gout.

XORTX Therapeutics (XRTX) announces the launch of a new late stage program to treat gout. The new drug development program – XRx-026 – will ...

Explore the latest advancements in heart disease medications, including statins, beta-blockers, ACE inhibitors, and more, for ...

Gout tophi totally disappeared and renal function remained stable. The patient continues to receive rasburicase treatment. P Richette is a Rheumatologist and T Bardin is a Professor of ...

Diseases of the joints are known as arthritis. The term is derived from the Greek word that means exactly that: diseases of ...

XORTX Therapeutics Inc. is a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease. The company is actively involved in creating ...

Discover how thorough prescription discussions between doctors and patients improve treatment outcomes and ensure patient ...